Showing 1 - 3 results of 3 for search 'F. van Rhee', query time: 0.02s Refine Results
  1. 1
    P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE

    P1140: TIME TO TUMOR, SYMPTOMATIC AND LABORATORY RESPONSES FOLLOWING SILTUXIMAB TREATMENT IN IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE by F. van Rhee, A. Rosenthal, K. Kanhai, R. Martin, K. Nishimura, A. Hoering, D. Fajgenbaum

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PRACTICE (THE INSURE STUDY)

    P925: IMPACT OF PRIOR TREATMENT EXPOSURE ON THE EFFECTIVENESS OF IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS TREATED IN ROUTINE CLINICAL PR... by H. C. Lee, K. Ramasamy, M. Macro, F. E. Davies, R. Abonour, F. van Rhee, V. T. Hungria, N. Puig, K. Ren, J. Silar, V. Enwemadu, D. Cherepanov, D. M. Stull, X. Leleu

    Published 2022-06-01
    Get full text
    Article
  3. 3
    Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

    Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing by L. Rasche, S. S. Chavan, O. W. Stephens, P. H. Patel, R. Tytarenko, C. Ashby, M. Bauer, C. Stein, S. Deshpande, C. Wardell, T. Buzder, G. Molnar, M. Zangari, F. van Rhee, S. Thanendrarajan, C. Schinke, J. Epstein, F. E. Davies, B. A. Walker, T. Meissner, B. Barlogie, G. J. Morgan, N. Weinhold

    Published 2017-08-01
    Get full text
    Article

Search Tools: